Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2014.053 | Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial | Prof. NG Siew Chien |
| 2014.039 | Can Virtual Reality exercise reduce the perception of handicap on elderly with dizziness and/ or balance problems in HK community? A randomized-control trial | Prof Tong Michael Chi-Fai |
| 2014.038 | A pilot study of surgical intervention for childhood obstructive sleep apnoea | Dr. Chan Dorothy, Fung Ying |
| 2014.034 | A randomized, controlled trial: transdiagnostic cognitive-behavioural therapy (TCBT) versus non-directive supportive therapy (NDST) for mood-related disorders in a sample of Chinese adults | Professor Leung Patrick |
| 2014.029 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY | Dr. TSANG Chiu Chi |
| 2014.028 | A Phase III, Open-Label, Extension Trial of ECU-NMO-301 to Evaluate the Safety and Efficacy of Eculizumab in Patients with Relapsing Neuromyelitis Optica (NMO) | Dr. LAU Alexander Yuk Lun |
| 2014.013 | Evaluation on the Efficacy of Advanced Treatment for Obstructive Sleep Apnea Patients without Polysomnography | Dr Leung Moon Wah |
| 2014.010 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY | Dr. OZAKI Risa |
| 2014.007 | Adjunctive vitamin D during antiviral treatment for chronic hepatitis B: a double-blind randomized trial | Dr Wong Lai Hung, Grace |
| 2014.005 | Effectiveness of an electronic Health Mobile Applications (e-Health apps) educational intervention in supporting the Self-Management of Coronary Heart Disease clients in the Community | Prof. WONG Eliza Mi Ling |
| 2013.686 | Effectiveness of Bowen Therapy in improving Physical Function, Activities of Daily Living and Work in people with Distal Radius Fracture | Miss. NG TSZ YAN |
| 2013.683 | A randomized controlled study of the effect of changes in bedtime on blood pressure in children and adolescents | Prof. Li Man Chim Albert Martin |
| 2013.680 | Cilostazol in Decreasing progression of cerebral white matter hyperintensities (DREAM) | Prof. MOK Vincent Chung Tong |
| 2013.677 | Consolidation of lifestyle modification program with mobile phone text messaging in patients with non-alcoholic fatty liver disease: A randomized controlled trial | Dr Wong Vincent |
| 2013.666 | A Randomized - Control Multi-Centers Study on The Safety and Effectiveness of Peri-Operative Transfusion Trigger Score (POTTS) | Dr Chan Simon Kin Cheong |
| 2013.662 | Improving Management and Patient Empowerment using Cloud Technology Among Hypertensives (IMPACT study): A randomised controlled trial. | Prof. YIP Hon Kei |
| 2013.659 | Accent Cardiac MRI Study - A clinical evaluation of the safety and efficacy of SJM MRI Conditional Pacing System in subjects undergoing Cardiac Magnetic Resonance Imaging (MRI) | Dr. CHAN Joseph Yat Sun |
| 2013.658 | A PHASE 3 DOUNLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDMIA AT RISK OF CARDIOVASCULAR EVENTS | Prof. YAN Bryan Ping Yen |
| 2013.653 | Clinical Evaluation of Frequency Compression Technology | Prof Kam Chi Shan |
| 2013.652 | Group psychoeducation : Feasibility and efficacy for Chinese outpatients with bipolar disorders in Hong Kong | Prof. So Suzanne Ho-Wai |
| 2013.649 | Clinical bioequivalence study on two trazodone formulations | Professor Lee Hon-leung, Vincent |
| 2013.644 | Intra-articular VS Intravenous Tranexamic Acid in Total Knee Arthroplasty – A Randomized Controlled Trial Comparing Effectiveness and Safety | Dr. CHUNG Kwong Yin |
| 2013.627 | Efficacy of Abdominal Acupuncture for Neck Pain: A Randomized Controlled Trial | Prof. GUO Yuanqi |
| 2013.621 | A retrospective analysis to review the efficacy and safety of rabbit anti-thymocyte globulin in the immunosuppressive therapy for the treatment of aplastic anemia | Dr Wong Siu Ming Raymond |
| 2013.609 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Prof. CHAN Juliana |
| 2013.606 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE | Dr. Kung Kenny |
| 2013.605 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After a Single Intravenous Dose of ARC-520 in Combination with Entecavir in Patients with Chronic Hepatitis B Virus (HBV) Infection, followed by a two-dose open label cohort and an open label single dose cohort in treatment naïve patients | Prof. CHAN Henry Lik Yuen |
| 2013.604 | A PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF PF-04950615 IN SUBJECTS WITH PRIMARY HYPERLIPIDEMIA OR MIXED DYSLIPIDEMIA AT RISK OF CARDIOVASCULAR EVENTS | Dr. SO Wing Yee |
| 2013.601 | Endoscopic ultrasound (EUS) guided cyanoacrylate injection for variceal obturation as secondary prophylaxis for patients at high risk of recurrent gastroesophageal variceal bleeding | Dr. TANG Raymond Shing Yan |
| 2013.596 | Clinical bioequivalence study on two escitalopram formulations | Professor Lee Hon-leung, Vincent |
| 2013.591 | A randomized controlled trial evaluating efficacy of promoting home-based HIV testing with online counseling on increasing HIV testing among men who have sex with men | Professor Lau Joseph Tak Fai |
| 2013.588 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY | Dr. LUK Andrea On Yan |
| 2013.587 | Quantitative Evaluation of the Efficacy of Herbs in Ischemic Stroke Patients Using Diffusion Tensor Imaging | Prof. WONG Ka Sing |
| 2013.586 | GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation (Phase II/III) | Prof. YAN Bryan Ping Yen |
| 2013.585 | Accuracy of HbA1c for Diagnosing Diabetes Mellitus among Hong Kong Chinese with Impaired Fasting Glucose | Prof. Sit Regina Wing Shan |
| 2013.584 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY | Dr. TSANG Chiu Chi |
| 2013.582 | RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE, THE VERTIS CV STUDY | Prof. LEE Alex Pui Wai |
| 2013.576 | Prevention of vasovagal reactions in blood donors: A Randomized double-blinded controlled comparison of efficacy and haemodynamic effects of oral prehydration fluids | Prof Khaw Kim Sun |
| 2013.568 | A 48 weeks, phase II, randomized, double-blind, placebo-controlled, proof of concept and dose finding study of three different dose regimens of BI 655066 administered subcutaneously in patients with ankylosing spondylitis. | Prof. TAM Lai Shan |
| 2013.564 | A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis | Prof. SZETO Cheuk Chun |
| 2013.561 | Randomized Double-Blinded Comparison of Intravenous Infusion Versus Intravenous Boluses for Administration of Norepinephrine for Maintenance of Blood Pressure during Spinal Anaesthesia for Caesarean Section | Prof. NGAN KEE Warwick |
| 2013.555 | A prospective randomized study in comparing the effects of the combined use of wrist extension splint and tennis elbow band with tennis elbow band alone for patients with lateral epicondylitis | Miss Ho Hiu Ting |
| 2013.554 | A Randomized Comparison of Medial and Lateral Approaches for Ultrasound Guided Infraclavicular Brachial Plexus Block | Prof Karmakar Manoj Kumar |
| 2013.551 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Positive, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2013.550 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B | Prof. WONG Grace Lai Hung |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2013.535 | Sanjiu Weitai Granules in the Treatment of Functional Dyspepsia: a Multi-center, Stratified Block Randomized, Double-blind and Placebo Parallel-controlled Clinical Study | Prof Wu Che Yuen Justin |
| 2013.532 | A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of the Efficacy and Safety of FG-4592 in the Treatment of Anemia in Incident-dialysis Patients | Professor SZETO Cheuk Chun |
| 2013.531 | A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A CHEMOKINE CCR2/5 RECEPTOR ANTAGONIST (PF-04634817) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY | Dr Ozaki Risa |
| 2013.516 | A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Tenofovir Alafenamide (TAF) 25 mg QD versus Tenofovir Disoproxil Fumarate (TDF) 300 mg QD for the Treatment of HBeAg-Negative, Chronic Hepatitis B | Dr. YIP Wai Man |
Page 225 of 263.